RADICAVA
Live / Registered — Registered — Sections 8 & 15 accepted and acknowledged (as of 08 Aug 2024)
What this means for you
Registered since 23 Jan 2018. The owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 87132086
- Registration number
- 5387607
- Mark type
- Design + words
- Filed
- 09 Aug 2016
- Published for opposition
- 01 Nov 2016
- Registered
- 23 Jan 2018
- Attorney of record
- Jeffrey L. Costellia
Goods and services
- Class 005 — Pharmaceuticals: Pharmaceutical preparations for the treatment of central nervous system diseases; Pharmaceutical preparations for protection against free radicals; Pharmaceutical preparations for removing free radicals from the human bodies; Neuroprotective medicines; Pharmaceutical preparations for the treatment of amyotrophic lateral sclerosis (ALS)
Owner
- K.K. BCJ-94, TOKYO, JP
- Mitsubishi Tanabe Pharma Corporation, Osaka, JP
- Mitsubishi Tanabe Pharma Corporation, Osaka, JP
- Mitsubishi Tanabe Pharma Corporation, Osaka, JP
Prosecution history
- 26 Nov 2025 — ASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY
- 03 Sept 2025 — AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP
- 08 Aug 2024 — NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED
- 08 Aug 2024 — REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.
- 06 Aug 2024 — CASE ASSIGNED TO POST REGISTRATION PARALEGAL
- 19 Jan 2024 — TEAS SECTION 8 & 15 RECEIVED
- 23 Jan 2023 — COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
- 23 Jan 2018 — REGISTERED-PRINCIPAL REGISTER
- 21 Dec 2017 — NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
- 20 Dec 2017 — ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
- 12 Dec 2017 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 11 Dec 2017 — STATEMENT OF USE PROCESSING COMPLETE
- 07 Dec 2017 — USE AMENDMENT FILED
- 11 Dec 2017 — SOU EXTENSION 2 GRANTED
- 07 Dec 2017 — SOU EXTENSION 2 FILED